Management of Low Total Testosterone with Low SHBG
When you encounter low total testosterone with low SHBG, you must measure free or bioavailable testosterone before making any treatment decisions, as the low SHBG artificially lowers total testosterone and may not reflect true androgen deficiency 1.
Understanding the Clinical Context
Low SHBG is most commonly caused by:
- Obesity (most common)
- Insulin resistance/metabolic syndrome/type 2 diabetes
- Hypothyroidism
- Nonalcoholic fatty liver disease
- Cushing's disease
- Medications (glucocorticoids, growth hormone, anabolic steroids) 1
The critical issue here is that total testosterone is SHBG-dependent—when SHBG is low, total testosterone drops proportionally even if free (bioavailable) testosterone remains normal 2, 3. This creates a diagnostic trap where you might incorrectly diagnose hypogonadism based solely on total testosterone.
Diagnostic Algorithm
Step 1: Measure Free or Bioavailable Testosterone
- Calculate free testosterone using the Vermeulen formula (most widely used method) 2, 4
- Alternatively, measure bioavailable testosterone
- Do NOT rely on total testosterone alone when SHBG is altered 1, 2
Step 2: Interpret Results Based on Free Testosterone
If free testosterone is normal (≥6.5 ng/dL):
- The patient does NOT have true hypogonadism 5
- Address the underlying cause of low SHBG (weight loss for obesity, optimize diabetes control, evaluate thyroid function)
- Do NOT initiate testosterone therapy 6
If free testosterone is low (<6.5 ng/dL):
- Confirm the patient has specific hypogonadal symptoms (reduced libido, erectile dysfunction, decreased spontaneous erections) 1
- Proceed with standard hypogonadism workup (LH, FSH, prolactin, morning repeat testing)
- Consider testosterone therapy only if symptoms are present AND confirmed biochemically 1, 6
Treatment Considerations
When Testosterone Therapy is Appropriate
If true hypogonadism is confirmed (low free testosterone + symptoms):
- Discuss potential benefits, harms, and costs with the patient 6
- Use intramuscular formulations over transdermal (similar efficacy, significantly lower cost) 6
- Reevaluate symptoms at 12 months—discontinue if no improvement in sexual function 6
- Monitor using free or bioavailable testosterone rather than total testosterone in patients with persistently low SHBG 3, 7
When Testosterone Therapy is NOT Appropriate
- Normal free testosterone despite low total testosterone 5
- Absence of specific hypogonadal symptoms 1
- Goals of improving energy, vitality, physical function, or cognition alone (insufficient evidence) 6
Critical Pitfalls to Avoid
Do not diagnose hypogonadism based on total testosterone alone when SHBG is low—this is the single most common error. Studies show 17.2% of men with erectile dysfunction have normal total testosterone but low free testosterone, and this rises to 26.3% in men over 60 5.
Do not ignore the underlying cause of low SHBG—obesity, insulin resistance, and metabolic syndrome are treatable conditions that may resolve the hormonal abnormality without testosterone therapy 1, 8.
Do not use testosterone therapy as a substitute for lifestyle modification—weight loss and metabolic optimization should be first-line management when low SHBG is driven by obesity or diabetes 8.
Recognize age-related SHBG changes—men over 60 have higher SHBG prevalence and are more likely to have discordant total vs. free testosterone 5. In this population, free testosterone measurement becomes even more critical.
Monitoring During Treatment
If testosterone therapy is initiated:
- Monitor free or bioavailable testosterone rather than total testosterone 3, 7
- Baseline SHBG levels may predict treatment response—men with very low SHBG (≤28 nmol/L) and younger age may show different responses to therapy 7
- Testosterone therapy itself will further suppress SHBG, making total testosterone an unreliable monitoring parameter 9